Brief: Anebulo Pharmaceuticals reports Q4 results
Sept 9 (Reuters) - Anebulo Pharmaceuticals Inc ANEB.O :
* ANEBULO PHARMACEUTICALS REPORTS FOURTH QUARTER AND FISCAL
YEAR
2022 FINANCIAL RESULTS AND HIGHLIGHTS RECENT BUSINESS PROGRESS
* ANEBULO PHARMACEUTICALS INC - CASH BALANCE WAS $14.5
MILLION AS
OF JUNE 30, 2022
* ANEBULO PHARMACEUTICALS INC - NET LOSS IN Q4 OF FISCAL
2022 WAS
$2.3 MILLION, OR $0.10 PER SHARE
Source text for Eikon: ID:nBw3MqwDda
Further company coverage: ANEB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anebulo Pharmaceuticals
See all newsAdvisory: Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn
Anebulo Pharmaceuticals Q2 net loss narrows
Brief: Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC
Anebulo Pharmaceuticals posts Q1 net loss
Brief: Anebulo Pharmaceuticals Reports Fourth Quarter And Fiscal Year 2025 Financial Results